Ning Han - Publications

Dihydroartemisinin-Loaded ZIF-8 Nanoparticles Elicit Chemo-Immunotherapy against Malignant Pleural Effusion via Inhibition of OCT4/M-CSF Signaling Pathway.

Journal: Molecular pharmaceutics

Published: April 23, 2026

ZIF-Derived FeCo Nanoparticles and FeN4 Single-Atom Sites for High-Performance Oxygen Evolution and Oxygen Reduction Bifunctional Electrocatalysis.

Journal: ChemSusChem

Published: March 10, 2026

Chlorin e6-mediated sublethal photodynamic therapy modulates biomarkers in a murine lung cancer-derived in vitro cancer-associated fibroblast model.

Journal: Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology

Published: February 26, 2026

Coordination-Modulated MOF-Derived Electrocatalysts for Enhanced C─C Coupling in CO2 to C2H4 and C2H5OH Conversion.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: February 16, 2026

Teniposide facilitates macrophage phagocytosis by targeting the CD47-SIRPα axis and the candidate protein TRIM54 in lung cancer.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: January 22, 2026

Cepharanthine-mediated PD-L1 autophagic degradation via regulation of TSPO and RILP boosts anti-lung cancer chemo-immunotherapy efficacy.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: December 30, 2025

Fundamentals and emerging frontiers in p53-targeted drug development.

Journal: Biochemistry and biophysics reports

Published: December 25, 2025

Regulation of tumorigenesis by cellular senescence: Mechanisms and pathways in liver cancer and cholangiocarcinoma.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: December 24, 2025

Defactinib inhibits focal adhesion kinase to attenuate pancreatic cancer growth via PI3K/AKT pathway modulation.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: December 09, 2025

Functional doxorubicin and iron ions dual-loaded carboxymethyl chitin-based microspheres for hepatocellular carcinoma therapy via embolization, ferroptosis, and autophagy-mediated HIF-1α inhibition.

Journal: International journal of pharmaceutics

Published: November 21, 2025

OTUD3-mediated deubiquitination licenses TEX264 to orchestrate ER-phagy for KDM5B degradation in teniposide lung cancer therapy.

Journal: European journal of pharmacology

Published: November 10, 2025

Targeted Nanoactuator-Integrated Multicomponent Supramolecular Assemblies for Augmented Chemo/Chemodynamic Combination Therapies.

Journal: Biomacromolecules

Published: October 01, 2025